Clinical Trials at Loma Linda University Medical Center

As of July 2026, 59 paid clinical trials are recruiting at Loma Linda University Medical Center, located at 11234 ANDERSON ST RM 1150, LOMA LINDA, CA 92354-2804, phone (909) 558-5075 in Loma Linda, California. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 16, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

59 clinical trials at Loma Linda University Medical Center

·Clear filters·↓ Download CSV

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

for Recurrent B Acute Lymphoblastic Leukemia

156 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: 1 - 21

Code: NCT02981628·Phase 2·Recruiting

Apply to this trial

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for Acute Leukemia of Ambiguous Lineage

Drug: Venetoclax

112 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: Up to 365 Days

Code: NCT06317662·Phase 2·Recruiting

Apply to this trial

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for Basal Ganglia Germinoma

92 locations incl. Mobile

Sponsor: Children's Oncology Group

Sex: All·Age: 3 - 29

Code: NCT06368817·Phase 2·Recruiting

Apply to this trial

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for Recurrent Langerhans Cell Histiocytosis

106 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 180 Days - 22

Code: NCT05828069·Phase 2·Recruiting

Apply to this trial

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for Ganglioneuroblastoma, Nodular

156 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: Up to 30

Code: NCT06172296·Phase 3·Recruiting

Apply to this trial

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for Low Grade Astrocytoma

Drug: Selumetinib

124 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 2 - 21

Code: NCT04166409·Phase 3·Recruiting

Apply to this trial

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

for Childhood Medulloblastoma

101 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: 4 - 21

Code: NCT05382338·Phase 3·Recruiting

Apply to this trial

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for Malignant Glioma

Drug: Selinexor

109 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 12 Months - 21

Code: NCT05099003·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for Stage II Nasopharyngeal Carcinoma AJCC v8

Drug: Nivolumab

76 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: Up to 21

Code: NCT06064097·Phase 2·Recruiting

Apply to this trial

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for Pleuropulmonary Blastoma

76 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 21

Code: NCT06647953·Phase 3·Recruiting

Apply to this trial

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

for Advanced Lung Neuroendocrine Tumor

29 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04665739·Phase 2·Recruiting

Apply to this trial

Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation

for Tobacco Use

2 locations incl. Loma Linda

Sponsor: Loma Linda University

Sex: Female·Age: 18+

Code: NCT06438549·Recruiting

Apply to this trial

Factors That Affect Trust Between Physicians and Patients

for Trust

1 location in Loma Linda

Sponsor: Loma Linda University

Sex: All·Age: 18+

Code: NCT06125431·Recruiting

Apply to this trial

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

for Malignant Testicular Germ Cell Tumor

5 locations incl. Birmingham

Sponsor: University of Southern California

Sex: Male·Age: 18+

Code: NCT06060873·Recruiting

Apply to this trial

Proton Therapy for Esophageal Cancer

for Esophagus Cancer

1 location in Loma Linda

Sponsor: Loma Linda University

Sex: All·Age: 18+

Code: NCT01684904·Recruiting

Apply to this trial

Proton Therapy in the Treatment of Liver Metastases

for Liver Metastases

1 location in Loma Linda

Sponsor: Loma Linda University

Sex: All·Age: 18+

Code: NCT01697371·Recruiting

Apply to this trial

Teamwork Makes the Dream Work

for HIV Infections

1 location in Loma Linda

Sponsor: Loma Linda University

Sex: All·Age: 18+

Code: NCT05866523·Recruiting

Apply to this trial

Effect of Magnesium Sulfate Bolus on Intraoperative Neuromonitoring

for Intraoperative Neurophysiological Monitoring

1 location in Loma Linda

Sponsor: Loma Linda University

Sex: All·Age: 18 - 80

Code: NCT04938765·Phase 4·Recruiting

Apply to this trial

Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).

for Blunt Cerebrovascular Injury

1 location in Loma Linda

Sponsor: Loma Linda University

Sex: All·Age: 18+

Code: NCT05868525·Phase 4·Recruiting

Apply to this trial